Paragon Bioservices pulls in $13 mln Series A

Paragon Bioservices has closed $13 million in Series A financing. NewSpring Capital and Camden Partners led the round. Evergreen Advisors and 1st BridgeHouse Securities served as advisors to Paragon. Based in Baltimore, Paragon is a contract research and manufacturer focused on biopharmaceuticals and vaccines.

North AmericaUSBriefs